Peter M. Hecht
2020 - Cyclerion Therapeutics
In 2020, Peter M. Hecht earned a total compensation of $366K as Chief Executive Officer at Cyclerion Therapeutics, a 201% increase compared to previous year.
Compensation breakdown
| Option Awards | $255,215 |
|---|---|
| Salary | $103,846 |
| Other | $6,932 |
| Total | $365,993 |
Hecht received $255.2K in option awards, accounting for 70% of the total pay in 2020.
Hecht also received $103.8K in salary and $6.9K in other compensation.
Rankings
In 2020, Peter M. Hecht's compensation ranked 11,756th out of 13,090 executives tracked by ExecPay. In other words, Hecht earned more than 10.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,756 out of 13,090 | 10th |
Division Manufacturing | 5,024 out of 5,624 | 11th |
Major group Chemicals And Allied Products | 2,055 out of 2,257 | 9th |
Industry group Drugs | 1,794 out of 1,957 | 8th |
Industry Pharmaceutical Preparations | 1,333 out of 1,462 | 9th |
Source: SEC filing on April 28, 2021.
Hecht's colleagues
We found two more compensation records of executives who worked with Peter M. Hecht at Cyclerion Therapeutics in 2020.
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019